Literature DB >> 12217946

The GABA(B) receptor agonists baclofen and CGP 44532 prevent acquisition of alcohol drinking behaviour in alcohol-preferring rats.

Giancarlo Colombo1, Salvatore Serra, Giuliana Brunetti, Giuliana Atzori, Marialaura Pani, Giovanni Vacca, Giovanni Addolorato, Wolfgang Froestl, Mauro A M Carai, Gian Luigi Gessa.   

Abstract

AIMS: The present study investigated the effect of the gamma-aminobutyric acid (GABA)(B) receptor agonists, baclofen and CGP 44532, on the acquisition of alcohol drinking behaviour in selectively bred Sardinian alcohol-preferring (sP) rats.
METHODS: Baclofen [0, 1 and 3 mg/kg, intraperitoneally (i.p.)] and CGP 44532 (0, 0.1, 0.3 and 1 mg/kg, i.p.) were administered immediately before alcohol presentation to alcohol-naive sP rats. Alcohol was offered under the two-bottle free-choice regimen with unlimited access for 24 h/day. Drug treatment was repeated once daily for 10 consecutive days.
RESULTS: Baclofen and CGP 44532, dose-dependently and with comparable efficacy, suppressed alcohol intake; compensatory increases in water intake left total fluid intakes virtually unchanged.
CONCLUSIONS: These results demonstrate that baclofen and CGP 44532 prevent the acquisition of alcohol drinking behaviour in sP rats, and suggest the involvement of the GABA(B) receptor in the mechanisms underlying the disclosure and experience of the reinforcing properties of alcohol in this rat line.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12217946     DOI: 10.1093/alcalc/37.5.499

Source DB:  PubMed          Journal:  Alcohol Alcohol        ISSN: 0735-0414            Impact factor:   2.826


  39 in total

1.  Tolerance to baclofen's sedative effect in alcohol-addicted patients: no dissipation after a period of abstinence.

Authors:  Giovanni Addolorato; Lorenzo Leggio; Ludovico Abenavoli; Fabio Caputo; Giovanni Gasbarrini
Journal:  Psychopharmacology (Berl)       Date:  2004-09-30       Impact factor: 4.530

2.  Complete suppression of craving in alcohol-dependent individuals: is it possible?

Authors:  Falk Kiefer
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

3.  Ethanol withdrawal-induced brain metabolites and the pharmacological effects of acamprosate in mice lacking ENT1.

Authors:  David J Hinton; Moonnoh R Lee; Taylor L Jacobson; Prasanna K Mishra; Mark A Frye; David A Mrazek; Slobodan I Macura; Doo-Sup Choi
Journal:  Neuropharmacology       Date:  2012-06       Impact factor: 5.250

4.  Efficacy and side effects of baclofen and the novel GABAB receptor positive allosteric modulator CMPPE in animal models for alcohol and cocaine addiction.

Authors:  Valentina Vengeliene; Tatiane T Takahashi; Olga A Dravolina; Irina Belozertseva; Edwin Zvartau; Anton Y Bespalov; Rainer Spanagel
Journal:  Psychopharmacology (Berl)       Date:  2018-04-12       Impact factor: 4.530

Review 5.  Management of alcohol dependence in patients with liver disease.

Authors:  Giovanni Addolorato; Antonio Mirijello; Lorenzo Leggio; Anna Ferrulli; Raffaele Landolfi
Journal:  CNS Drugs       Date:  2013-04       Impact factor: 5.749

6.  Intra-nucleus accumbens shell injections of R(+)- and S(-)-baclofen bidirectionally alter binge-like ethanol, but not saccharin, intake in C57Bl/6J mice.

Authors:  Chelsea R Kasten; Stephen L Boehm
Journal:  Behav Brain Res       Date:  2014-07-12       Impact factor: 3.332

Review 7.  Building better strategies to develop new medications in Alcohol Use Disorder: Learning from past success and failure to shape a brighter future.

Authors:  Nazzareno Cannella; Massimo Ubaldi; Alessio Masi; Massimo Bramucci; Marisa Roberto; Angelo Bifone; Roberto Ciccocioppo
Journal:  Neurosci Biobehav Rev       Date:  2019-05-18       Impact factor: 8.989

Review 8.  Potential of GABAB Receptor Positive Allosteric Modulators in the Treatment of Alcohol Use Disorder.

Authors:  Paola Maccioni; Giancarlo Colombo
Journal:  CNS Drugs       Date:  2019-02       Impact factor: 5.749

9.  Inhibition of 5alpha-reduced steroid biosynthesis impedes acquisition of ethanol drinking in male C57BL/6J mice.

Authors:  Matthew M Ford; Naomi Yoneyama; Moriah N Strong; Andrea Fretwell; Michelle Tanchuck; Deborah A Finn
Journal:  Alcohol Clin Exp Res       Date:  2008-06-28       Impact factor: 3.455

Review 10.  Animal models for medications development targeting alcohol abuse using selectively bred rat lines: neurobiological and pharmacological validity.

Authors:  Richard L Bell; Helen J K Sable; Giancarlo Colombo; Petri Hyytia; Zachary A Rodd; Lawrence Lumeng
Journal:  Pharmacol Biochem Behav       Date:  2012-07-25       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.